BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9577692)

  • 1. Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
    S D J Med; 1998 Apr; 51(4):127-32. PubMed ID: 9577692
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment and control of vancomycin resistant enterococci.
    Fraise AP
    J Antimicrob Chemother; 1996 Nov; 38(5):753-6. PubMed ID: 8961044
    [No Abstract]   [Full Text] [Related]  

  • 3. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin resistant enterococci healthcare associated infections.
    Orsi GB; Ciorba V
    Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of vancomycin-resistant enterococcus in health care facilities in a region.
    Ostrowsky BE; Trick WE; Sohn AH; Quirk SB; Holt S; Carson LA; Hill BC; Arduino MJ; Kuehnert MJ; Jarvis WR
    N Engl J Med; 2001 May; 344(19):1427-33. PubMed ID: 11346807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococci.
    Palmer SM; Rybak MJ
    Pharmacotherapy; 1996; 16(5):819-29. PubMed ID: 8888077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlling VRE.
    Jacobson AF; Winslow EH
    Am J Nurs; 1999 Jun; 99(6):68. PubMed ID: 10489565
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities.
    Greenaway CA; Miller MA
    Infect Control Hosp Epidemiol; 1999 May; 20(5):341-3. PubMed ID: 10349951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control measures for a VRE outbreak in a haemodialysis unit].
    Diguio N; Chanet P; Hautemanière A; Cao-Huu T; Hartemann P; Kessler M
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S272-80. PubMed ID: 19596348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to approach management of an outbreak caused by enterococci].
    Pasquarella C
    Ann Ig; 2000; 12(4 Suppl 2):115-21. PubMed ID: 11100561
    [No Abstract]   [Full Text] [Related]  

  • 14. Vancomycin-resistant enterococci. Mechanism and clinical relevance.
    Eliopoulos GM
    Infect Dis Clin North Am; 1997 Dec; 11(4):851-65. PubMed ID: 9421703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.
    Simonsen GS; Andersen BM; Digranes A; Harthug S; Jacobsen T; Lingaas E; Natås OB; Olsvik O; Ringertz SH; Skulberg A; Syversen G; Sundsfjord A
    Scand J Infect Dis; 1998; 30(5):465-8. PubMed ID: 10066045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures.
    Boyce JM
    Infect Dis Clin North Am; 1997 Jun; 11(2):367-84. PubMed ID: 9187952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
    Lior L; Litt M; Hockin J; Kennedy C; Jolley BA; Garcia M; Gillis G; Humar A; Campbell I; Brunton J; Dedier H; Conly J
    Can Commun Dis Rep; 1996 Aug; 22(15):125-8. PubMed ID: 8791860
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit.
    Malik RK; Montecalvo MA; Reale MR; Li K; Maw M; Munoz JL; Gedris C; van Horn K; Carnevale KA; Levi MH; Dweck HS
    Pediatr Infect Dis J; 1999 Apr; 18(4):352-6. PubMed ID: 10223689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E; Cataldo MA
    Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.